Back to search

Article

Genome-wide CRISPRi-seq identified ferredoxin-NADP reductase FprB as a synergistic target for gallium therapy in <i>Pseudomonas aeruginosa</i>

2024-09-01

Abstract excerpt

With the rise of antibiotic-resistant bacteria, non-antibiotic therapies like gallium are increasingly gaining attention. Gallium ions exhibit potent activity against multidrug-resistant bacteria and intravenous gallium nitrite is under phase 2 clinical trials to treat chronic Pseudomonas aeruginosa infections in cystic fibrosis patients. However, its clinical efficacy is constrained by the achievable peak concen...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
9c19bea5-1520-56c8-bb25-5007398e0b53
DOI
10.1101/2024.09.01.610675
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Genome-wide CRISPRi-seq identified ferredoxin-NADP reductase FprB as a synergistic target for gallium therapy in <i>Pseudomonas aeruginosa</i>DOI 10.1101/2024.09.01.610675
Select a neighboring publication to make it the new centre.